Article Details
Retrieved on: 2021-01-12 18:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Donanemab is unique among the cadre of anti-Aβ monoclonal antibodies ... In a Phase 1b trial, the antibody had demonstrated prowess at plaque ...
Article found on: www.alzforum.org
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here